Efficacité du facteur VII activé recombinant dans l'hémorragie alvéolaire diffuse

rF VIIa is a promising treatment for diffuse, persistent alveolar haemorrhage, with only a small dose required to be effective. Future studies are needed in order to establish a clear protocol for the administration of this novel agent.